Indivior PLC (IZQVF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $20.97. It has a SharesGrow Score of 67/100, indicating a above average investment profile with 4 out of 7 criteria passed.
Financials: revenue is $1.2B, +12.2%/yr average growth. Net income is $210M, growing at +3501.3%/yr. Net profit margin is 16.9% (healthy). Gross margin is 80.2% (-0.7 pp trend).
Balance sheet: total debt is $351M with negative equity of -$98M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.71 (tight liquidity). Debt-to-assets is 29.2%. Total assets: $1.2B.
SharesGrow 7-Criteria breakdown: Value 85/100 (Pass), Growth 90/100 (Pass), Past 75/100 (Partial), Health 25/100 (Fail), Moat 70/100 (Pass), Future ?/100 (Fail), Income 70/100 (Pass).
